Leimenstoll G, Schlegelberger T, Fulde R, Niedermayer W
I. Medizinische Universitätsklinik, Abteilung für Nephrologie, Kiel.
Dtsch Med Wochenschr. 1988 Mar 31;113(13):514-5. doi: 10.1055/s-2008-1067674.
A 34-year-old patient prophylactically received tuberculostatic treatment with ethambutol and isoniazide after having had an allogenic renal transplant and immunosuppression with methylprednisolone and cyclosporine. The tuberculostatic treatment was discontinued 165 days after the transplantation. The cyclosporine blood level, which was measured daily thereafter, gradually rose from 250 ng/ml to 400 ng/ml. It is possible that enzyme induction due by the tuberculostatic drugs was responsible for the increased breakdown of cyclosporine.
一名34岁患者在接受同种异体肾移植并用甲基泼尼松龙和环孢素进行免疫抑制后,预防性地接受了乙胺丁醇和异烟肼的抗结核治疗。抗结核治疗在移植后165天停止。此后每天测量的环孢素血药浓度从250 ng/ml逐渐升至400 ng/ml。抗结核药物引起的酶诱导可能是环孢素分解增加的原因。